Alignment Healthcare, Inc. (ALHC) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ALHC Revenue Growth
Revenue Breakdown (FY 2023)
ALHC's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
ALHC Revenue Analysis (2019–2025)
As of May 6, 2026, Alignment Healthcare, Inc. (ALHC) generated trailing twelve-month (TTM) revenue of $4.26 billion, reflecting explosive growth of +33.3% year-over-year. The most recent quarter (Q1 2026) recorded $1.24 billion in revenue, up 22.0% sequentially.
Looking at the longer-term picture, ALHC's 5-year compound annual growth rate (CAGR) stands at +32.7%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $3.95 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows ALHC's business is primarily driven by Health Care, Premium (93%), and Health Care Capitation (7%). With over half of revenue concentrated in Health Care, Premium, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CNC (+17.0% YoY), MOH (+7.7% YoY), and CVS (+7.8% YoY), ALHC has outperformed the peer group in terms of revenue growth. Compare ALHC vs CNC →
ALHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ALHCCurrent | $4.3B | +33.3% | +32.7% | 0.4% | |
 CNC | $194.8B | +17.0% | +11.9% | -3.9% | |
 MOH | $45.4B | +7.7% | +18.5% | 1.7% | |
 CVS | $402.1B | +7.8% | +8.4% | 2.6% | |
 HUM | $129.7B | +14.1% | +10.9% | 1.1% | |
 ELV | $199.1B | +9.4% | +10.3% | 4.1% |
ALHC Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.95B | +46.1% | $488.6M | 12.4% | $14.8M | 0.4% |
| 2024 | $2.70B | +48.3% | $296.7M | 11.0% | $-101,555,000 | -3.8% |
| 2023 | $1.82B | +27.2% | $201.0M | 11.0% | $-127,817,000 | -7.0% |
| 2022 | $1.43B | +22.8% | $184.3M | 12.8% | $-128,639,000 | -9.0% |
| 2021 | $1.17B | +21.7% | $128.7M | 11.0% | $-178,072,000 | -15.2% |
| 2020 | $959.2M | +26.7% | $166.2M | 17.3% | $-5,263,000 | -0.5% |
| 2019 | $757.0M | - | $95.6M | 12.6% | $-29,484,000 | -3.9% |
See ALHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonALHC — Frequently Asked Questions
Quick answers to the most common questions about buying ALHC stock.
Is ALHC's revenue growth accelerating or slowing?
ALHC revenue is accelerating at +33.3% year-over-year, exceeding the 5-year CAGR of +32.7%. TTM revenue reached $4.3B. Growth momentum has increased versus prior periods.
What is ALHC's long-term revenue growth rate?
Alignment Healthcare, Inc.'s 5-year revenue CAGR of +32.7% reflects the sustained expansion pattern. Current YoY growth of +33.3% is above this long-term average.
How is ALHC's revenue distributed by segment?
ALHC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.